Richard S Lindahl Emergent Bio Solutions Inc. (EBS) insider trading activity

Richard S Lindahl is EVP, Chief Financial Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 299,225 shares of EBS, which is worth approximately $1.71 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 819 shares (Common Stock) at a price of $97.15 per share, resulting in proceeds of $79,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 299K

74.98% 3M change

88.5% 12M change

Total Value Held $1.71 Million

RICHARD S LINDAHL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2021	SELL Payment of exercise price or tax liability	$79,566 $97.15 p/Share	819 Reduced 2.11%	37,973 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$94,425 $93.49 p/Share	1,010 Reduced 2.54%	38,792 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	8,023 Added 16.78%	39,802 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$311,341 $123.45 p/Share	2,522 Reduced 7.35%	31,779 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	2,495 Added 6.78%	34,301 Common Stock

Also insider at

CMPX

Compass Therapeutics, Inc. Healthcare

Director

RSL